-+ 0.00%
-+ 0.00%
-+ 0.00%

Acurx Pharmaceuticals Announces $7.1M Registered Direct Offering Of 825,085 Shares At $3.03/Share

Benzinga·04/16/2026 12:10:19
Listen to the news

$2.5 million upfront with up to an additional $4.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants